Brought to you by 
Arthrex gets rights to distribute Osiris' Cartiform allograft
05 Feb 2015
Executive Summary
Regenerative medicine firm Osiris Therapeutics Inc. licensed orthopedic device company Arthrex Inc. exclusive rights to distribute its Cartiform viable cartilage mesh.
Deal Industry
- Medical Devices
- Pharmaceuticals
-
Medical Devices
- Biomaterials
- Implantable Devices
-
Biotechnology
- Gene Therapy, Cell Therapy
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com